全部

1·The overall survival curves of the 2 cohorts were superimposable, the researchers commented.

研究人员评论说，这两个队列的总体生存曲线是可叠加的。

2·The primary outcome measure was overall survival.

主要终点为总体生存率。

3·Obviously, the most important endpoint is overall survival.

显然，最重要的终点是总体生存率。

4·Median overall survival of all 211 patients was 49.3 months.

所有211名患者的中位总存活数是49.3个月。

5·Overall survival was better in patients who received adjuvant CT-RT.

接受过辅助放化疗的胰腺癌患者有较长的存活时间。

6·But it doesn't improve breast cancer patients' overall survival rate.

但它没有提高乳腺癌患者的总生存率。

7·The outcome parameters assessed were overall survival and tumor-related survival.

预后参数评估包括总生存率和肿瘤相关生产率。

8·Primary efficacy endpoints were overall survival and time to symptomatic progression.

主要效果终端指标为总生存率和症状进展时间。

9·All 185 patients were included in the analysis of progression-free and overall survival.

全部185名患者参与了无疾病进展及总体生存的分析。

10·Secondary end points included overall survival (OS) and overall response rate (ORR) per IRC.

次要终点包括IRC评估的总生存期(OS)和总缓解率(ORR)。